Work for Onconova Therapeutics, Inc.?

Claim Your Profile

Onconova Therapeutics, Inc. Logo Image

Onconova Therapeutics, Inc.

About Onconova Therapeutics, Inc.

11-50 Employees
Based in Newtown, Pennsylvania

Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS). Rigosertib, Onconova's lead candidate, is a proprietary Phase 3 small molecule agent, which the Company believes blocks cellular signaling by targeting RAS effector pathways.

Ticker:
ONTX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol